$ORMP
Oramed Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Oramed Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is ORMP down today? It is at $3.57 (-3.25%), and our scanner flagged it 26 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ORMP spikes, and full due diligence on ORMP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ORMP 26 times in the last 30 days. Create a free account to track $ORMP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ORMP traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on ORMP on Friday, peaking at 15.7x its normal volume.
Likely catalystOther Material Event, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kidron Miriam Officer | Acquired (grant/award) | +599K 1.4% of company | added 39% | 2.15M | n/a | Nov 12, 26 |
Gabay Avraham Officer | Acquired (grant/award) | +599K 1.4% of company | added 70% | 1.46M | n/a | Nov 12, 26 |
Hexter Joshua Officer | Acquired (grant/award) | +599K 1.4% of company | added 45% | 1.93M | n/a | Nov 12, 26 |
Kidron Nadav Officer | Acquired (grant/award) | +1.32M 3.0% of company | added 32% | 5.46M | n/a | Nov 12, 26 |
Aghion Daniel Director | Acquired (grant/award) | +76K 0.2% of company | added 67% | 189K | n/a | Nov 12, 26 |
Mayer Arie Director | Acquired (grant/award) | +74K 0.2% of company | added 44% | 242K | n/a | Nov 12, 26 |
Shapiro Benjamin Director | Acquired (grant/award) | +74K 0.2% of company | added 60% | 197K | n/a | Nov 12, 26 |
Reznick Yehuda Director | Acquired (grant/award) | +76K 0.2% of company | added 72% | 181K | n/a | Nov 12, 26 |
Hexter Joshua Officer | Sold (automatic/other) | -30K 0.07% of company | sold 2.2% | 1.33M | $135K at $4.51 | Oct 1, 26 |
Gabay Avraham Officer | Sold (automatic/other) | -20K 0.05% of company | sold 2.3% | 861K | $90K at $4.51 | Oct 1, 26 |
Gabay Avraham Officer | Acquired (grant/award) | +209K 0.5% of company | added 31% | 881K | n/a | Sep 24, 26 |
Kidron Miriam Officer | Acquired (grant/award) | +417K 1.0% of company | added 37% | 1.55M | n/a | Sep 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ORMP traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on ORMP on Friday, peaking at 15.7x its normal volume.
ORMP last traded at $3.57, down 3.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ORMP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ORMP 26 times in the last 30 days.
ORMP (Oramed Pharmaceuticals Inc.) trades on XNAS, with a market cap of about $155M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ORMP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ORMP discussion
Sign in to ask a question or join the discussion.